Bio Essence Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOE research report →
Price Chart
About the company
Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements.
- CEO
- Yin Yan
- IPO
- 2022
- Employees
- 4
- HQ
- Irvine, CA, US
Get TickerSpark's AI analysis on BIOE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.21M
- P/E
- 4.88
- PEG
- 0.00
- P/S
- 2.48
- P/B
- 3.95
- EV/EBITDA
- 5.34
- Div Yield
- 0.00%
- Gross Margin
- 69.68%
- Op Margin
- 52.86%
- Net Margin
- 52.12%
- ROE
- -142.50%
- ROIC
- 38.84%
Latest fiscal year · YoY change
- Revenue
- $1.90M+485.8%
- Gross Profit
- $1.43M+558.0%
- Op Income
- $900.01K
- Net Income
- $896.20K+168.5%
- EPS
- $0.02+168.6%
- OCF Growth
- +151.6%
- FCF Growth
- +151.6%
- 52W High
- $0.52
- 52W Low
- $0.05
- 50D MA
- $0.22
- 200D MA
- $0.21
- Beta
- 6.10
- RSI (14)
- 4
- Avg Volume
- 323
No earnings-call transcripts are available for BIOE yet.
- Free Float
- 9.5%
- Shares Outstanding
- 39.60M
- Float Shares
- 3.76M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 28, 24 | Yan Yin | sell | 140,000 |
| Oct 30, 24 | Yan Yin | sell | 143,845 |
| Oct 29, 24 | Yan Yin | sell | 40,000 |
| Jun 6, 23 | Yan Yin | buy | 5,000,000 |
| Sep 25, 24 | Yan Yin | sell | 50,000 |
| Sep 26, 24 | Yan Yin | sell | 40,000 |
| Sep 27, 24 | Yan Yin | sell | 200 |
| Sep 30, 24 | Yan Yin | sell | 1,990 |
| Jul 2, 24 | Yan Yin | sell | 50,000 |
| Jul 3, 24 | Yan Yin | sell | 100,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BIOE coverage
Recent articles, reports, and earnings notes.
No research on BIOE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOE report →Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
accessnewswire.com · Apr 27
BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026
accessnewswire.com · Mar 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.